‘Well Vanilla Didn’t Work; We’ll Try French Vanilla’: What We Heard This Week


“That’s sort of going, ‘Well vanilla didn’t work; we’ll try French vanilla.'” — Gary Sachs, MD, of Massachusetts General Hospital in Boston, on the benefits of adjunctive cariprazine (Vraylar) for patients who have failed on multiple first-line antidepressants.

“Here we are, waking up in yet another scenario where we have, in this case, children that are slaughtered at an elementary school. And I’m just, honestly, sad. I’m angry.” — gun-violence survivor Joseph Sakran, MD, MPA, MPH, of Johns Hopkins Medicine in Baltimore, on the recent mass shooting at an elementary school in Uvalde, Texas.

“It is very slippery, and it mutates rapidly.” — James Lawler, MD, MPH, of the University of Nebraska Medical Center’s Global Center for Health Security in Omaha, discussing whether SARS-CoV-2 might become a seasonal virus.

“These people are clearly suffering. They are clearly disabled by this.” — Michael Sneller, MD, of the NIH in Bethesda, Maryland, on the discrepancy between persistent symptoms and test results in people with long COVID.

“Much of the editorial is supported by no references at all and simply represents the author’s own views.” — Gideon Meyerowitz-Katz, PhD, of the University of Wollongong in Australia, slamming an article pushing falsehoods about the pandemic in a peer-reviewed neurosurgery journal.

“What we have difficulty imagining is what a world looks like where you have an infection and there is no antibiotic and it’s widespread.” — Sen. Michael Bennet (D-Colo.), discussing the looming “global catastrophe” of antibiotic resistance.

“People were scrambling in doing what they had to do and they all found their unique solution.” — Dawn Velligan, PhD, of the University of Texas Health Science Center at San Antonio, on how telepsychiatry adapted to meet patient needs during the pandemic.

“Our interpretation is that the virus itself does not cross into CSF in any significant way.” — Arvid Edén, MD, PhD, of the University of Gothenburg in Sweden, on detecting viral antigen in cerebrospinal fluid (CSF) of COVID-19 patients.

Articles You May Like

AAP recommends breastfeeding for 2 years
Gene discovery may explain why more women get Alzheimer’s disease
Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters
Plant that traps prey underground is the 1st of its kind to be discovered
How to prevent tick bites

Leave a Reply

Your email address will not be published.